About Neovasc (TSE:NVC)
Neovasc Inc. (Neovasc) is a specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. The Company's segment is the development, manufacture and marketing of medical devices. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer for the treatment of refractory angina, and tissue products. The Tiara is in preclinical/early clinical stage development to provide a minimally invasive transcatheter device for patients experiencing mitral regurgitation (MR) as a result of mitral heart valve disease. The Reducer is an hourglass-shaped, balloon-expandable, stainless steel, bare metal device, which is implanted in the coronary sinus, creating a restriction in venous outflow from the myocardium (the muscular layer of the heart wall). Neovasc produces Peripatch, a biological tissue product that is manufactured from pericardium.
Industry, Sector and Symbol
Trailing P/E Ratio4.45
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on Assets-22.34%
Neovasc (TSE:NVC) Frequently Asked Questions
What is Neovasc's stock symbol?
Neovasc trades on the Toronto Stock Exchange (TSX) under the ticker symbol "NVC."
When will Neovasc make its next earnings announcement?
Who are some of Neovasc's key competitors?
Some companies that are related to Neovasc include Trez Capital Mortgage Investment (TZZ), Primero Mining (P), Chinook Energy (CKE), Perpetual Energy (PMT), Concordia International (CXR), Eastern Platinum (ELR), McCoy Global (MCB), Foraco International (FAR), Canadian Zinc (CZN), Horizons Active Cdn Dividend Etf (HAL), TAG Oil (TAO), Touchstone Exploration (TXP), Strongco (SQP), WesternOne (WEQ), LWP Capital (LWP), Enterprise Group (E), Arsenal Energy (AEI) and ENTREC (ENT).
Who are Neovasc's key executives?
Neovasc's management team includes the folowing people:
- Paul L. Geyer, Independent Chairman of the Board
- Fred Colen, President, Chief Executive Officer
- Christopher Clark, Chief Financial Officer, Corporate Secretary
- Brian McPherson, Chief Operating Officer
- Vicki Lee Bebeau, Vice President - Clinical Affairs
- Randy Lane, Vice President - Research & Development
- Alexei J. Marko, Director
- Jane H. Hsiao Ph.D., Independent Director (Age 69)
- Douglas Glen Janzen, Independent Director
- William O'Neill, Independent Director (Age 61)
Has Neovasc been receiving favorable news coverage?
Media stories about NVC stock have trended somewhat positive on Sunday, according to Accern Sentiment Analysis. The research firm scores the sentiment of news coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Neovasc earned a news sentiment score of 0.16 on Accern's scale. They also gave news stories about the company an impact score of 45.35 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.
How do I buy shares of Neovasc?
Shares of NVC and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Neovasc's stock price today?
One share of NVC stock can currently be purchased for approximately C$1.78.
How big of a company is Neovasc?
Neovasc has a market capitalization of C$25.23 million.
How can I contact Neovasc?
Neovasc's mailing address is 13562 Maycrest Way Suite 5138, RICHMOND, BC V6V 2J7, Canada. The company can be reached via phone at +1-604-2704344.
MarketBeat Community Rating for Neovasc (NVC)MarketBeat's community ratings are surveys of what our community members think about Neovasc and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Neovasc (TSE:NVC) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Neovasc (TSE:NVC) Earnings History and Estimates Chart
Neovasc (TSE NVC) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|3/22/2018|| || || || || || || || |
|11/14/2017||Q3 2017||C($0.02)||C($0.08)||C$2.29 million||C$1.73 million||View||N/A|
|8/10/2017||Q2 2017||C($0.03)||C($0.05)||C$1.92 million||C$1.76 million||View||N/A|
|5/10/2017||Q1 2017||C($0.13)||C$1.96 million||View||N/A|
|3/23/2017||Q4 2016||C$0.63||C$3.69 million||View||N/A|
|11/14/2016||Q3 2016||C($0.15)||C$3.96 million||View||N/A|
|8/9/2016||Q2 2016||C($0.26)||C$2.21 million||View||N/A|
|4/29/2016||Q1 2016||C($0.14)||C$2.76 million||View||N/A|
|3/29/2016||Q4 2015||C($0.15)||C$2.97 million||View||N/A|
|11/9/2015||Q3 2015||C($0.15)||C$3.24 million||View||N/A|
|8/6/2015||Q2 2015||C($0.12)||C$3.60 million||View||N/A|
|5/12/2015||Q1 2015||C($0.10)||C$2.86 million||View||N/A|
|3/30/2015||Q4 2014||C($0.14)||C$3.35 million||View||N/A|
|11/13/2014||Q3 2014||C($0.09)||C$4.27 million||View||N/A|
|8/13/2014||Q2 2014||C($0.12)||C$4.41 million||View||N/A|
|5/22/2014||Q1 2014||C($0.01)||C$3.84 million||View||N/A|
|4/17/2014||Q4 2013||C($0.04)||C$3.31 million||View||N/A|
|11/20/2013||Q3 2013||C($0.03)||C$3.63 million||View||N/A|
|8/15/2013||Q2 2013||C($0.03)||C$2.79 million||View||N/A|
|5/28/2013||Q1 2013||C($0.04)||C$2.01 million||View||N/A|
Neovasc (TSE:NVC) Earnings Estimates
2018 EPS Consensus Estimate: $0.00
(Earnings estimates data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for Neovasc (TSE:NVC)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Neovasc (TSE NVC)
No insider trades for this company have been tracked by MarketBeat.com
Neovasc (TSE NVC) News Headlines
Neovasc (TSE:NVC) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Neovasc (TSE NVC) Stock Chart for Sunday, March, 18, 2018